Hospitalization of newborns and young infants for chickenpox in France.
Chickenpox is often considered more severe during the first year of life, but its course is usually mild during the first 3 months of life, presumably owing to the persistence of maternal antibodies. Hospitalization and intravenous acyclovir therapy are generally restricted to severe cases but also systematically recommended in newborns in France, irrespective of the clinical severity of the infection. This recommendation was launched in 1998 when Varicella zoster virus (VZV)-specific immunoglobulins were not available in the country and has remained unchanged since. The aim of this prospective observational study was to describe complications of varicella infection in a population of 745 children hospitalized for varicella before 1 year of age, with a specific focus on newborns. Complications occurred in 65% of cases. They were very rare before the age of 1 month (10%) but their incidence then increased progressively with age and probably the disappearance of maternal antibodies: 42% (1-2 months), 66% (3-5 months), 70% (6-8 months), and 79% (9-12 months). Conclusion Chickenpox is usually mild in newborns because most of them are protected by VZV maternal antibodies. Unless the absence of maternal VZV immunity is demonstrated, newborns with mild chickenpox should not require antiviral therapy.
Lécuyer
Aurélie
A
Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV), Saint Maur des Fossés, France. activ@activfrance.fr
Levy
Corinne
C
Gaudelus
Joel
J
Floret
Daniel
D
Soubeyrand
Benoit
B
Caulin
Evelyne
E
Cohen
Robert
R
Grimprel
Emmanuel
E
D016009:Chi-Square Distribution; D002644:Chickenpox / Q000150:complications / Q000453:epidemiology*; D005260:Female; D005602:France / Q000453:epidemiology; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011446:Prospective Studies; D012307:Risk Factors
Clin Vaccine Immunol. 2009 Apr;16(4):484-7
19176690
Med J Aust. 2001 Mar 19;174(6):288-92
11297117
Pediatr Infect Dis J. 2006 Jan;25(1):41-4
16395101
Pediatr Infect Dis. 1985 Sep-Oct;4(5):503-7
4047961
Vaccine. 2006 Apr 12;24(16):3258-60
16459000
Clin Microbiol Infect. 2007 May;13(5):546-9
17378927
Epidemiol Infect. 2002 Dec;129(3):599-606
12558344
Vaccine. 2001 Apr 30;19(23-24):3097-103
11312004
Epidemiol Infect. 2007 Jan;135(1):131-8
16740185
Biken J. 1980 Mar;23(1):9-14
6254500
Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):22-5
1523475
Pediatrics. 1976 Nov;58(5):692-6
185578
J Pediatr. 1996 Oct;129(4):529-36
8859259